SciELO - Scientific Electronic Library Online

 
vol.30 issue2Technical efficiency assessment of public primary care providers in the Basque Country (Spain), 2010-2013Analysis of barriers and legal-ethical opportunities for disclosure and apology for medical errors in Spain author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Gaceta Sanitaria

Print version ISSN 0213-9111

Abstract

MATTOZO ROVER, Marina Raijche; VARGAS-PELAEZ, Claudia Marcela; ROCHA FARIAS, Mareni  and  NAIR LEITE, Silvana. Access to high-cost drugs in Brazil from the perspective of physicians, pharmacists and patients. Gac Sanit [online]. 2016, vol.30, n.2, pp.110-116. ISSN 0213-9111.  https://dx.doi.org/10.1016/j.gaceta.2015.12.005.

Objective: To explore perceptions on access to medication supplied by the Specialized Component of Pharmaceutical Assistance (CEAF) within the Brazilian Unified Health System (which includes high-cost drugs) by the actors involved in the healthcare services of this component. Method: A descriptive, qualitative study was carried out by using a focal group with 7 users and 11 semi-structured interviews with health professionals (physicians and pharmacist) in the state of Santa Catarina. Results: According to the participants, access to medicines had improved. Two main perceptions of the CEAF Clinical Guidelines were identified: the requirements constitute a bureaucracy that limits access, and the requisites increase the demand for tests and specialized healthcare services, exceeding the capacity of the healthcare services network. These assumptions generated the search for other means of access that revealed a lack of information and understanding of the right to health among the users. In addition, according to the participants, because of the difficulties of accessing services as a whole, full access to CEAF medicines is a goal that remains to be achieved. Conclusion: Although access to CEAF medicines has improved, there are still some difficulties in guaranteeing treatment access and comprehensiveness.

Keywords : Pharmaceutical services; Health services accessibility; Clinical practice guidelines as topic; Drugs, essential; Technology, high-cost; Brazil.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License